Egal Pads
Series A in 2025
Egal Pads is a manufacturer specializing in menstrual products designed for easy access and use in public restrooms. Their primary product is pads on a roll, which can be dispensed as conveniently as toilet paper from existing dispensers, promoting equality and convenience during menstruation.
Wavely Diagnostics
Seed Round in 2023
Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care.
Kubik is an environmental technology company focused on constructing low-carbon, durable, and affordable buildings. By utilizing plastic waste as a primary material, Kubik transforms this waste into sustainable building solutions for residential, commercial, and public facilities. The company's innovative approach not only addresses the issue of plastic waste but also provides customers with environmentally friendly living spaces that prioritize sustainability and durability.
Integrated Reality Labs
Pre Seed Round in 2023
Integrated Reality Labs (IRL Inc.) specializes in developing integrated reality (IR) games and tools that enhance real-world play. Their patent-pending Integrated Reality Technology Platform uses Ultra-Wideband, Bluetooth, mobile location services, and other device sensors to power products like SLAP, a mobile app that transforms classic games like Assassin, HvZ, and Tag into more engaging and accessible experiences. IRL Inc. aims to empower users to create, share, and monetize their own mobile-powered real-world games, similar to the user-generated content model of Roblox.
Massive Bio
Seed Round in 2020
Massive Bio, Inc., established in 2014, specializes in connecting cancer patients with clinical trials through its AI-powered platform. The company offers patient identification, pre-screening, and enrollment assistance, primarily targeting community practices. Massive Bio's services aim to streamline drug development for pharmaceutical companies by providing access to relevant patient data while addressing 'last mile' issues such as site and financial considerations of patients. The company caters to cancer patients, oncologists, payers, and insurance companies, operating two platforms: a B2C platform offering on-demand products and services for patients and primary oncologists, and a B2B platform designed for hospitals and insurance companies. Massive Bio's headquarters are in New York City, with an additional office in Newtown, Pennsylvania.
Well Traveled
Angel Round in 2020
Well Traveled is a members-only social platform designed for travelers, foodies, and adventure seekers. The company provides a private community that facilitates travel discovery, planning, and booking. Through its platform, members gain access to trusted recommendations and exclusive perks, enabling them to connect with local communities and share insider information about trending destinations. Well Traveled aims to enhance the travel experience by helping users plan exceptional trips and find suitable accommodations, ultimately fostering memorable journeys.
HUE.AI is an innovative company focused on revolutionizing the optical and medical industries through artificial intelligence. Operating under its parent company, Cyborg Industries, HUE.AI has developed proprietary technology that integrates machine learning with advanced insights in chemistry, optics, and materials science to enhance human visual acuity and color perception. Its flagship software, MAIDAS, is recognized as the first AI system designed specifically for optimizing optical performance and aesthetic appeal. HUE.AI offers a range of products ready for licensing, including specialized lenses aimed at correcting color vision deficiencies, blocking blue light, and providing progressive vision solutions. By leveraging AI technology, HUE.AI aims to assist eyewear manufacturers and optical product designers in improving their offerings, reducing costs, and accelerating product development timelines. Through its innovative approach, HUE.AI is poised to lead the next generation of optical solutions.
QSM Diagnostics
Seed Round in 2018
QSM Diagnostics, Inc. is a Boston-based company that specializes in developing and manufacturing point-of-care diagnostics for bacterial infections, particularly in veterinary medicine. Founded in 2014 as a spin-out from the Goluch Group at Northeastern University, the company leverages decades of expertise in sensor development. QSM Diagnostics focuses on creating electrochemical sensors and medical devices designed to identify ear infections caused by the Pseudomonas aeruginosa bacteria in dogs. Its innovative testing kits employ single-use disposable sensor technology to detect target molecules, allowing veterinarians to monitor and diagnose infections effectively at the wound site. This capability enhances the ability of veterinary professionals to improve diagnosis and treatment plans, ultimately leading to better care for animals.